暂无数据
代码股票名称
最新价涨跌额涨跌幅成交量成交额今开昨收最高最低总市值流通市值总股本流通股本5日涨跌幅10日涨跌幅20日涨跌幅60日涨跌幅120日涨跌幅250日涨跌幅年初至今涨跌幅股息率TTM换手率市盈率TTM市盈率(静)振幅所属行业
美股期权个股详情
MDRX240621C7500
- 1.00
- +0.50+100.00%
延时15分钟行情收盘价 05/28 15:15 (美东)
1.00最高价1.00最低价
1.00今开0.50昨收1张成交量1644张未平仓合约数7.50行权价100.00成交额0.00%隐含波动率-2.86%溢价2024/06/21到期日1.25内在价值100合约乘数24天距到期日0.00时间价值100合约规模美式期权类型--Delta--Gamma8.75杠杆倍数--Theta--Rho--有效杠杆--Vega
分时
- 5日
- 日K
新闻
TD Cowen 将 Veradigm 维持在买入水平
TD Cowen 将 Veradigm 维持在买入水平
快讯 | 道明考恩维持对Veradigm的买入，将目标股价下调至15美元
Veradigm 分析师评级
日期上行/下行分析师公司目标股价变动评级变动之前/当前评级 2024 年 5 月 28 日 81.25% TD Cowen 26 美元 → 15 美元维持在 2024 年 3 月 19 日买入 20.84% 德意志银行 15 美元 → 10 美元下调评级 Bu
快讯 | Veradigm——不打算任命任何长期高管，同时另行宣布正在探索战略替代方案
快讯 | 汤姆·兰根被任命为Veradigm的临时首席执行官
快讯 | Veradigm Inc：将探索潜在的战略替代方案，其中可能包括出售、合并、战略业务合并或其他交易
评论
Veradigm's promising ROCE trend and its capacity to yield higher returns on less capital is noteworthy. Despite the stock's five-year decline, these trends may warrant further investigation.
Returns At Veradigm (NASDAQ:MDRX) Are On The Way UpThe acquisition is a major chance for Veradigm to broaden its revenue services and utilize more capabilities, says Brian Hall, CEO of Koha Health, seeing it as an opportunity to gain more resources for their client's financial triumph and upgraded patient experience.
Though Veradigm seems undervalued, the pessimistic forecast implies notable risk, raising doubts about intensifying MDRX portfolio exposure. Despite present undervaluation, potential investors considering an entry now must assess negative future growth predictions.
$Veradigm(MDRX.US$2022年财报至今未出，5年来营收除2020年下滑8%以外增长了4年，平均增速仅有1.6%，营业利润从2018到2020年均亏损，2021年靠大幅削减费用扭亏达到0.89亿，净利润靠非经营收入达到1.3亿。
2022前3季度营收增长6.2%，营业利润萎缩40%，净利润受停止经营利润影响重新进入亏损区间。
财报延误通常不是好现象，加上近期财务数据的大起大落，暂时缺乏投资价值。
2022前3季度营收增长6.2%，营业利润萎缩40%，净利润受停止经营利润影响重新进入亏损区间。
财报延误通常不是好现象，加上近期财务数据的大起大落，暂时缺乏投资价值。
$Veradigm(MDRX.US$ reports earnings for the last 3 months and a full year on February 25th. after recently pulling back I feel like this talk is at a good price point to make an entry and also try to front run the earnings call strategy groups who usually only seem to look a week ahead. this was a position I wanted to enter before I noticed this scenario so it works out well. having any kind of telemedicine in your portfolio right now is a good thing I think...
1
阅读更多